Anaptysbio Inc (NQ: ANAB )

14.60 USD +0.30 (+2.10%)

Official Closing Price Updated: 4:00 PM EDT, Sep 25, 2020 Add to My Watchlist

Price and Volume

Volume	224,900
Open	14.14
Bid (Size)	13.01 (1)
Ask (Size)	18.00 (1)
Prev. Close	14.30
Today's Range	13.92 - 14.71
52wk Range	10.00 - 39.48
Shares Outstanding	23,497,680
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

AnaptysBio to Present at the 2020 Cantor Global Virtual Healthcare Conference

September 11, 2020

ANAPTYSBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating AnaptysBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

September 01, 2020

Performance

YTD	-8.12%	-8.12%
1 Month	-13.20%	-13.20%
3 Month	-35.63%	-35.63%
6 Month	+3.25%	+3.25%
1 Year	-58.57%	-58.57%

More News

AnaptysBio Announces Second Quarter 2020 Financial Results and Provides Pipeline Updates

August 10, 2020

AnaptysBio Reports Top-Line Data from Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps

August 10, 2020

AnaptysBio to Present at The 2020 Wedbush PacGrow Healthcare Conference

August 05, 2020

AnaptysBio Appoints Dr. Paul F. Lizzul As Chief Medical Officer

July 31, 2020

Shuman Glenn & Stecker Investigates AnaptysBio, Inc.

August 24, 2020

AnaptysBio Expands Executive Leadership Team

July 15, 2020

AnaptysBio Announces Orphan Drug Designation of Imsidolimab For Treatment of Generalized Pustular Psoriasis

July 08, 2020

Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Contact the Firm; Should Management be Held Accountable for Investors' Losses?

July 02, 2020

AnaptysBio (ANAB) Shares Cross Below 200 DMA

August 24, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.